Amplitude Surgical SA (EPA: AMPLI)

Market Cap	167.90M
Revenue (ttm)	106.02M
Net Income (ttm)	1.53M
Shares Out	47.97M
EPS (ttm)	0.03
PE Ratio	110.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	611
Average Volume	578
Open	3.260
Previous Close	3.260
Day's Range	3.260 - 3.280
52-Week Range	2.700 - 3.660
Beta	0.49
RSI	60.13
Earnings Date	Mar 26, 2025

About Amplitude Surgical

Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. The company ex...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1997
• Employees: 389
• Stock Exchange: Euronext Paris
• Ticker Symbol: AMPLI

Financial Performance

In 2024, Amplitude Surgical's revenue was 106.02 million, an increase of 5.81% compared to the previous year's 100.20 million. Earnings were 1.53 million, a decrease of -96.11%.